Global Esophageal Disorders Treatment Market Research Report 2024

Report ID: 1818894 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Esophageal Disorders Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Antacids
        1.2.3 H2 Blockers
        1.2.4 Proton Pump Inhibitors
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Esophageal Disorders Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Esophageal Disorders Treatment Market Perspective (2017-2028)
    2.2 Esophageal Disorders Treatment Growth Trends by Region
        2.2.1 Esophageal Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Esophageal Disorders Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Esophageal Disorders Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Esophageal Disorders Treatment Market Dynamics
        2.3.1 Esophageal Disorders Treatment Industry Trends
        2.3.2 Esophageal Disorders Treatment Market Drivers
        2.3.3 Esophageal Disorders Treatment Market Challenges
        2.3.4 Esophageal Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Esophageal Disorders Treatment Players by Revenue
        3.1.1 Global Top Esophageal Disorders Treatment Players by Revenue (2017-2022)
        3.1.2 Global Esophageal Disorders Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Esophageal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Esophageal Disorders Treatment Revenue
    3.4 Global Esophageal Disorders Treatment Market Concentration Ratio
        3.4.1 Global Esophageal Disorders Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Esophageal Disorders Treatment Revenue in 2021
    3.5 Esophageal Disorders Treatment Key Players Head office and Area Served
    3.6 Key Players Esophageal Disorders Treatment Product Solution and Service
    3.7 Date of Enter into Esophageal Disorders Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Esophageal Disorders Treatment Breakdown Data by Type
    4.1 Global Esophageal Disorders Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Esophageal Disorders Treatment Forecasted Market Size by Type (2023-2028)
5 Esophageal Disorders Treatment Breakdown Data by Application
    5.1 Global Esophageal Disorders Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Esophageal Disorders Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Esophageal Disorders Treatment Market Size (2017-2028)
    6.2 North America Esophageal Disorders Treatment Market Size by Country (2017-2022)
    6.3 North America Esophageal Disorders Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Esophageal Disorders Treatment Market Size (2017-2028)
    7.2 Europe Esophageal Disorders Treatment Market Size by Country (2017-2022)
    7.3 Europe Esophageal Disorders Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Esophageal Disorders Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Esophageal Disorders Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Esophageal Disorders Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Esophageal Disorders Treatment Market Size (2017-2028)
    9.2 Latin America Esophageal Disorders Treatment Market Size by Country (2017-2022)
    9.3 Latin America Esophageal Disorders Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Esophageal Disorders Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Esophageal Disorders Treatment Introduction
        11.1.4 Pfizer Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Bristol-Myers Squibb Company
        11.2.1 Bristol-Myers Squibb Company Company Detail
        11.2.2 Bristol-Myers Squibb Company Business Overview
        11.2.3 Bristol-Myers Squibb Company Esophageal Disorders Treatment Introduction
        11.2.4 Bristol-Myers Squibb Company Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.2.5 Bristol-Myers Squibb Company Recent Development
    11.3 Perrigo Company Plc
        11.3.1 Perrigo Company Plc Company Detail
        11.3.2 Perrigo Company Plc Business Overview
        11.3.3 Perrigo Company Plc Esophageal Disorders Treatment Introduction
        11.3.4 Perrigo Company Plc Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.3.5 Perrigo Company Plc Recent Development
    11.4 AstraZeneca Plc
        11.4.1 AstraZeneca Plc Company Detail
        11.4.2 AstraZeneca Plc Business Overview
        11.4.3 AstraZeneca Plc Esophageal Disorders Treatment Introduction
        11.4.4 AstraZeneca Plc Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.4.5 AstraZeneca Plc Recent Development
    11.5 GlaxoSmithKline Plc
        11.5.1 GlaxoSmithKline Plc Company Detail
        11.5.2 GlaxoSmithKline Plc Business Overview
        11.5.3 GlaxoSmithKline Plc Esophageal Disorders Treatment Introduction
        11.5.4 GlaxoSmithKline Plc Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.5.5 GlaxoSmithKline Plc Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Detail
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Esophageal Disorders Treatment Introduction
        11.6.4 Johnson & Johnson Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Teva Pharmaceuticals
        11.7.1 Teva Pharmaceuticals Company Detail
        11.7.2 Teva Pharmaceuticals Business Overview
        11.7.3 Teva Pharmaceuticals Esophageal Disorders Treatment Introduction
        11.7.4 Teva Pharmaceuticals Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.7.5 Teva Pharmaceuticals Recent Development
    11.8 Medtronic Plc
        11.8.1 Medtronic Plc Company Detail
        11.8.2 Medtronic Plc Business Overview
        11.8.3 Medtronic Plc Esophageal Disorders Treatment Introduction
        11.8.4 Medtronic Plc Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.8.5 Medtronic Plc Recent Development
    11.9 Torax Medical
        11.9.1 Torax Medical Company Detail
        11.9.2 Torax Medical Business Overview
        11.9.3 Torax Medical Esophageal Disorders Treatment Introduction
        11.9.4 Torax Medical Revenue in Esophageal Disorders Treatment Business (2017-2022)
        11.9.5 Torax Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Esophageal Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Antacids
    Table 3. Key Players of H2 Blockers
    Table 4. Key Players of Proton Pump Inhibitors
    Table 5. Key Players of Others
    Table 6. Global Esophageal Disorders Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Esophageal Disorders Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Esophageal Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Esophageal Disorders Treatment Market Share by Region (2017-2022)
    Table 10. Global Esophageal Disorders Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Esophageal Disorders Treatment Market Share by Region (2023-2028)
    Table 12. Esophageal Disorders Treatment Market Trends
    Table 13. Esophageal Disorders Treatment Market Drivers
    Table 14. Esophageal Disorders Treatment Market Challenges
    Table 15. Esophageal Disorders Treatment Market Restraints
    Table 16. Global Esophageal Disorders Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Esophageal Disorders Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Esophageal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Esophageal Disorders Treatment as of 2021)
    Table 19. Ranking of Global Top Esophageal Disorders Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Esophageal Disorders Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Esophageal Disorders Treatment Product Solution and Service
    Table 23. Date of Enter into Esophageal Disorders Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Esophageal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Esophageal Disorders Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Esophageal Disorders Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Esophageal Disorders Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Esophageal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Esophageal Disorders Treatment Revenue Market Share by Application (2017-2022)
    Table 31. Global Esophageal Disorders Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Esophageal Disorders Treatment Revenue Market Share by Application (2023-2028)
    Table 33. North America Esophageal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Esophageal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Esophageal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Esophageal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Esophageal Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Esophageal Disorders Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Esophageal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Esophageal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Pfizer Company Detail
    Table 44. Pfizer Business Overview
    Table 45. Pfizer Esophageal Disorders Treatment Product
    Table 46. Pfizer Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 47. Pfizer Recent Development
    Table 48. Bristol-Myers Squibb Company Company Detail
    Table 49. Bristol-Myers Squibb Company Business Overview
    Table 50. Bristol-Myers Squibb Company Esophageal Disorders Treatment Product
    Table 51. Bristol-Myers Squibb Company Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 52. Bristol-Myers Squibb Company Recent Development
    Table 53. Perrigo Company Plc Company Detail
    Table 54. Perrigo Company Plc Business Overview
    Table 55. Perrigo Company Plc Esophageal Disorders Treatment Product
    Table 56. Perrigo Company Plc Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 57. Perrigo Company Plc Recent Development
    Table 58. AstraZeneca Plc Company Detail
    Table 59. AstraZeneca Plc Business Overview
    Table 60. AstraZeneca Plc Esophageal Disorders Treatment Product
    Table 61. AstraZeneca Plc Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 62. AstraZeneca Plc Recent Development
    Table 63. GlaxoSmithKline Plc Company Detail
    Table 64. GlaxoSmithKline Plc Business Overview
    Table 65. GlaxoSmithKline Plc Esophageal Disorders Treatment Product
    Table 66. GlaxoSmithKline Plc Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 67. GlaxoSmithKline Plc Recent Development
    Table 68. Johnson & Johnson Company Detail
    Table 69. Johnson & Johnson Business Overview
    Table 70. Johnson & Johnson Esophageal Disorders Treatment Product
    Table 71. Johnson & Johnson Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 72. Johnson & Johnson Recent Development
    Table 73. Teva Pharmaceuticals Company Detail
    Table 74. Teva Pharmaceuticals Business Overview
    Table 75. Teva Pharmaceuticals Esophageal Disorders Treatment Product
    Table 76. Teva Pharmaceuticals Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 77. Teva Pharmaceuticals Recent Development
    Table 78. Medtronic Plc Company Detail
    Table 79. Medtronic Plc Business Overview
    Table 80. Medtronic Plc Esophageal Disorders Treatment Product
    Table 81. Medtronic Plc Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 82. Medtronic Plc Recent Development
    Table 83. Torax Medical Company Detail
    Table 84. Torax Medical Business Overview
    Table 85. Torax Medical Esophageal Disorders Treatment Product
    Table 86. Torax Medical Revenue in Esophageal Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 87. Torax Medical Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Esophageal Disorders Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Antacids Features
    Figure 3. H2 Blockers Features
    Figure 4. Proton Pump Inhibitors Features
    Figure 5. Others Features
    Figure 6. Global Esophageal Disorders Treatment Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Online Pharmacy Case Studies
    Figure 10. Others Case Studies
    Figure 11. Esophageal Disorders Treatment Report Years Considered
    Figure 12. Global Esophageal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Esophageal Disorders Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Esophageal Disorders Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global Esophageal Disorders Treatment Market Share by Players in 2021
    Figure 16. Global Top Esophageal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Esophageal Disorders Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Esophageal Disorders Treatment Revenue in 2021
    Figure 18. North America Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Esophageal Disorders Treatment Market Share by Country (2017-2028)
    Figure 20. United States Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Esophageal Disorders Treatment Market Share by Country (2017-2028)
    Figure 24. Germany Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Esophageal Disorders Treatment Market Share by Region (2017-2028)
    Figure 32. China Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Esophageal Disorders Treatment Market Share by Country (2017-2028)
    Figure 40. Mexico Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Esophageal Disorders Treatment Market Share by Country (2017-2028)
    Figure 44. Turkey Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Esophageal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Pfizer Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 47. Bristol-Myers Squibb Company Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 48. Perrigo Company Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 49. AstraZeneca Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 50. GlaxoSmithKline Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 51. Johnson & Johnson Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 53. Medtronic Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 54. Torax Medical Revenue Growth Rate in Esophageal Disorders Treatment Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Bristol-Myers Squibb Company
Perrigo Company Plc
AstraZeneca Plc
GlaxoSmithKline Plc
Johnson & Johnson
Teva Pharmaceuticals
Medtronic Plc
Torax Medical
Frequently Asked Questions
Esophageal Disorders Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Esophageal Disorders Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Esophageal Disorders Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Three Mouth Flask

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More